The global glucose injection market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Glucose injection is a type of glucose solution made up of dextrose and water. It contains high amounts of sugar to enable raise the blood sugar levels quickly in persons who have low blood sugar (hypoglycemia). The market’s considerable rise may be due to factors such as the rising incidence of diabetes and the growing number of health awareness initiatives launched by various health organizations. Presently, type-1 diabetes accounts for roughly 10% of all the global diabetes cases (with type-2 accounting for the remaining share). The factor contributing to the growth of the global glucose injection market include the rising healthcare expenditure on diabetes. According to the International Diabetes Federation (IDF), the annual global health spending on diabetes was about $760 billion in 2019.
(Get 15% Discount on Buying this Report)
Get a Free Sample Copy of Glucose Injection Market at: https://orionmarketreports.com/request-sample/?id=101167&submit=Request+Sample%0D%0A
Scope of the Glucose Injection Report
The research study analyzes the Glucose Injection industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
A full report on the Glucose Injection Market is available at: https://orionmarketreports.com/glucose-injection-market-2/101167/
Glucose Injection Market Segmentation:
By Type
- 5% Injection
- 10% Injection
- 50% Injection
- 70% Injection
- Others
By Application
- Diabetes
- Sports
- Others
Some key players operating in the market include Pfizer Inc., and Baxter International Inc., among others. These players are eyeing on strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships and collaborations, new product launches in the existing product portfolio, and so on. Moreover, partnerships and collaborations for sale of glucose injection has been witnessed in the market. In October 2018, Lupin announced the partnership with Eli Lilly and Company (India) to distribute Eli Lilly’s diabetes injection Aplevant in the country. This partnership with Eli Lilly is intended to increase access to diabetes medicines in India. Under the new partnership, Lupin will distribute and market Lilly’s Aplevant (dulaglutide), once a weekly injection for type 2 diabetes treatment.
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Glucose Injection Market Report
- What was the Glucose Injection Market size in 2021 and 2027; what are the estimated growth trends and market forecast (2022-2028).
- What will be the CAGR of Glucose Injection Market during the forecast period (2022-2028)?
- Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
- Which manufacturer/vendor/players in the Glucose Injection Market was the market leader in 2020?
- Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the Glucose Injection market.
- The market share of the Glucose Injection market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Glucose Injection market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the Glucose Injection market.
About Us:
Orion Market Reports (OMR) endeavor to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
